The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Non-Invasive Prenatal Testing-Global Market Insights and Sales Trends 2025
Synopsis
Non-Invasive Prenatal Testing is a method of determining the risk that the fetus will be born with certain genetic abnormalities. This testing analyzes small fragments of DNA that are circulating in a pregnant woman's blood
The global Non-Invasive Prenatal Testing market size is expected to reach US$ 10060 million by 2029, growing at a CAGR of 10.7% from 2023 to 2029. The market is mainly driven by the significant applications of Non-Invasive Prenatal Testing in various end use industries. The expanding demands from the 0-12 Weeks, 13-24 Weeks and 25-36 Weeks,, are propelling Non-Invasive Prenatal Testing market. High & Average Risk, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Low Risk segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Non-Invasive Prenatal Testing market, driven by demand from China, the second largest economy with some signs of stabilising, the Non-Invasive Prenatal Testing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Non-Invasive Prenatal Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Non-Invasive Prenatal Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Non-Invasive Prenatal Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Non-Invasive Prenatal Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Non-Invasive Prenatal Testing covered in this report include Sequenom, Roche, Natera, LabCorp, BGI Genomics, Quest Diagnostics, Illumina and Berry Genomics, etc.
The global Non-Invasive Prenatal Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sequenom
Roche
Natera
LabCorp
BGI Genomics
Quest Diagnostics
Illumina
Berry Genomics
Global Non-Invasive Prenatal Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Non-Invasive Prenatal Testing market, Segment by Type:
High & Average Risk
Low Risk
Global Non-Invasive Prenatal Testing market, by Application
0-12 Weeks
13-24 Weeks
25-36 Weeks
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Non-Invasive Prenatal Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Non-Invasive Prenatal Testing is a method of determining the risk that the fetus will be born with certain genetic abnormalities. This testing analyzes small fragments of DNA that are circulating in a pregnant woman's blood
The global Non-Invasive Prenatal Testing market size is expected to reach US$ 10060 million by 2029, growing at a CAGR of 10.7% from 2023 to 2029. The market is mainly driven by the significant applications of Non-Invasive Prenatal Testing in various end use industries. The expanding demands from the 0-12 Weeks, 13-24 Weeks and 25-36 Weeks,, are propelling Non-Invasive Prenatal Testing market. High & Average Risk, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Low Risk segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Non-Invasive Prenatal Testing market, driven by demand from China, the second largest economy with some signs of stabilising, the Non-Invasive Prenatal Testing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Non-Invasive Prenatal Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Non-Invasive Prenatal Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Non-Invasive Prenatal Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Non-Invasive Prenatal Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Non-Invasive Prenatal Testing covered in this report include Sequenom, Roche, Natera, LabCorp, BGI Genomics, Quest Diagnostics, Illumina and Berry Genomics, etc.
The global Non-Invasive Prenatal Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sequenom
Roche
Natera
LabCorp
BGI Genomics
Quest Diagnostics
Illumina
Berry Genomics
Global Non-Invasive Prenatal Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Non-Invasive Prenatal Testing market, Segment by Type:
High & Average Risk
Low Risk
Global Non-Invasive Prenatal Testing market, by Application
0-12 Weeks
13-24 Weeks
25-36 Weeks
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Non-Invasive Prenatal Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Non-Invasive Prenatal Testing
1.1 Non-Invasive Prenatal Testing Market Overview
1.1.1 Non-Invasive Prenatal Testing Product Scope
1.1.2 Non-Invasive Prenatal Testing Market Status and Outlook
1.2 Global Non-Invasive Prenatal Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Non-Invasive Prenatal Testing Market Size by Region (2018-2029)
1.4 Global Non-Invasive Prenatal Testing Historic Market Size by Region (2018-2023)
1.5 Global Non-Invasive Prenatal Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Non-Invasive Prenatal Testing Market Size (2018-2029)
1.6.1 North America Non-Invasive Prenatal Testing Market Size (2018-2029)
1.6.2 Europe Non-Invasive Prenatal Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Non-Invasive Prenatal Testing Market Size (2018-2029)
1.6.4 Latin America Non-Invasive Prenatal Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Non-Invasive Prenatal Testing Market Size (2018-2029)
2 Non-Invasive Prenatal Testing Market by Type
2.1 Introduction
2.1.1 High & Average Risk
2.1.2 Low Risk
2.2 Global Non-Invasive Prenatal Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Non-Invasive Prenatal Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Non-Invasive Prenatal Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Non-Invasive Prenatal Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Non-Invasive Prenatal Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Non-Invasive Prenatal Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Non-Invasive Prenatal Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Non-Invasive Prenatal Testing Revenue Breakdown by Type (2018-2029)
3 Non-Invasive Prenatal Testing Market Overview by Application
3.1 Introduction
3.1.1 0-12 Weeks
3.1.2 13-24 Weeks
3.1.3 25-36 Weeks
3.2 Global Non-Invasive Prenatal Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Non-Invasive Prenatal Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Non-Invasive Prenatal Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Non-Invasive Prenatal Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Non-Invasive Prenatal Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Non-Invasive Prenatal Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Non-Invasive Prenatal Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Non-Invasive Prenatal Testing Revenue Breakdown by Application (2018-2029)
4 Non-Invasive Prenatal Testing Competition Analysis by Players
4.1 Global Non-Invasive Prenatal Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Non-Invasive Prenatal Testing as of 2022)
4.3 Date of Key Players Enter into Non-Invasive Prenatal Testing Market
4.4 Global Top Players Non-Invasive Prenatal Testing Headquarters and Area Served
4.5 Key Players Non-Invasive Prenatal Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Non-Invasive Prenatal Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Sequenom
5.1.1 Sequenom Profile
5.1.2 Sequenom Main Business
5.1.3 Sequenom Non-Invasive Prenatal Testing Products, Services and Solutions
5.1.4 Sequenom Non-Invasive Prenatal Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Sequenom Recent Developments
5.2 Roche
5.2.1 Roche Profile
5.2.2 Roche Main Business
5.2.3 Roche Non-Invasive Prenatal Testing Products, Services and Solutions
5.2.4 Roche Non-Invasive Prenatal Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Roche Recent Developments
5.3 Natera
5.3.1 Natera Profile
5.3.2 Natera Main Business
5.3.3 Natera Non-Invasive Prenatal Testing Products, Services and Solutions
5.3.4 Natera Non-Invasive Prenatal Testing Revenue (US$ Million) & (2018-2023)
5.3.5 LabCorp Recent Developments
5.4 LabCorp
5.4.1 LabCorp Profile
5.4.2 LabCorp Main Business
5.4.3 LabCorp Non-Invasive Prenatal Testing Products, Services and Solutions
5.4.4 LabCorp Non-Invasive Prenatal Testing Revenue (US$ Million) & (2018-2023)
5.4.5 LabCorp Recent Developments
5.5 BGI Genomics
5.5.1 BGI Genomics Profile
5.5.2 BGI Genomics Main Business
5.5.3 BGI Genomics Non-Invasive Prenatal Testing Products, Services and Solutions
5.5.4 BGI Genomics Non-Invasive Prenatal Testing Revenue (US$ Million) & (2018-2023)
5.5.5 BGI Genomics Recent Developments
5.6 Quest Diagnostics
5.6.1 Quest Diagnostics Profile
5.6.2 Quest Diagnostics Main Business
5.6.3 Quest Diagnostics Non-Invasive Prenatal Testing Products, Services and Solutions
5.6.4 Quest Diagnostics Non-Invasive Prenatal Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Quest Diagnostics Recent Developments
5.7 Illumina
5.7.1 Illumina Profile
5.7.2 Illumina Main Business
5.7.3 Illumina Non-Invasive Prenatal Testing Products, Services and Solutions
5.7.4 Illumina Non-Invasive Prenatal Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Illumina Recent Developments
5.8 Berry Genomics
5.8.1 Berry Genomics Profile
5.8.2 Berry Genomics Main Business
5.8.3 Berry Genomics Non-Invasive Prenatal Testing Products, Services and Solutions
5.8.4 Berry Genomics Non-Invasive Prenatal Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Berry Genomics Recent Developments
6 North America
6.1 North America Non-Invasive Prenatal Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Non-Invasive Prenatal Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Non-Invasive Prenatal Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Non-Invasive Prenatal Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Non-Invasive Prenatal Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Non-Invasive Prenatal Testing Market Dynamics
11.1 Non-Invasive Prenatal Testing Industry Trends
11.2 Non-Invasive Prenatal Testing Market Drivers
11.3 Non-Invasive Prenatal Testing Market Challenges
11.4 Non-Invasive Prenatal Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
